Literature DB >> 2984506

Neurotensin is produced by and secreted from classic small cell lung cancer cells.

T W Moody, D N Carney, L Y Korman, A F Gazdar, J D Minna.   

Abstract

The presence of neurotensin in various human tumor cell lines was investigated by radioimmunoassay. High concentrations (0.06-5.1 pmol/mg protein) were detected in 50% of the classic but not variant small cell lung cancer or other human tumor cell lines examined. Biochemical studies indicated that the main peak of immunoreactivity coeluted with synthetic neurotensin using gel filtration and high pressure liquid chromatography techniques. Also, the rate of neurotensin secretion increased approximately 2-fold when theophylline was added which elevated intracellular levels of cAMP 4-fold. Because neurotensin is present in and secreted from many classic small cell lung cancer cells, it may function as a regulatory peptide in this disease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984506     DOI: 10.1016/0024-3205(85)90555-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

Review 1.  Pathogenesis of lung cancer: 100 year report.

Authors:  York E Miller
Journal:  Am J Respir Cell Mol Biol       Date:  2005-09       Impact factor: 6.914

2.  Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.

Authors:  Yanli Zhang; Shunqin Zhu; Liang Yi; Yaling Liu; Hongjuan Cui
Journal:  Mol Cell Biochem       Date:  2013-12-20       Impact factor: 3.396

3.  HMC-1 human mast cells synthesize neurotensin (NT) precursor, secrete bioactive NT-like peptide(s) and express NT receptor NTS1.

Authors:  David E Cochrane; Robert E Carraway; Kimberly Harrington; Melissa Laudano; Stephen Rawlings; Ross S Feldberg
Journal:  Inflamm Res       Date:  2011-09-17       Impact factor: 4.575

4.  Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.

Authors:  Terry W Moody; Irene Ramos-Alvarez; Robert T Jensen
Journal:  Peptides       Date:  2022-08-03       Impact factor: 3.867

5.  Expression of neurotensin messenger RNA in a human carcinoid tumor.

Authors:  B M Evers; J Ishizuka; C M Townsend; S Rajaraman; J C Thompson
Journal:  Ann Surg       Date:  1991-10       Impact factor: 12.969

6.  Neurotensin expression and release in human colon cancers.

Authors:  B M Evers; J Ishizuka; D H Chung; C M Townsend; J C Thompson
Journal:  Ann Surg       Date:  1992-10       Impact factor: 12.969

7.  SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.

Authors:  Terry W Moody; Daniel C Chan; Samuel A Mantey; Paola Moreno; Robert T Jensen
Journal:  Life Sci       Date:  2014-02-02       Impact factor: 5.037

8.  Peptides and growth factors in small cell lung cancer: production, binding sites, and growth effects.

Authors:  G Bepler; M Rotsch; G Jaques; M Haeder; J Heymanns; G Hartogh; P Kiefer; K Havemann
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

9.  Neurotensin receptors regulate transactivation of the EGFR and HER2 in a reactive oxygen species-dependent manner.

Authors:  Terry W Moody; Lingaku Lee; Irene Ramos-Alvarez; Robert T Jensen
Journal:  Eur J Pharmacol       Date:  2019-10-12       Impact factor: 4.432

10.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.